About

About Novalis VC Novalis Biotech is an early stage venture capital investor in life sciences. We welcome innovative concepts in TechBio and aim to support their development already at the state of incorporation. Our investment focus is “enabling technologies” in life sciences. We strongly believe in capital light platform technology and close interaction with customers already early in the life of the company. Focus areas are: innovative research and manufacturing tools, bioinformatics, genomics, diagnostics and digital health. We focus on early-stage start-ups, from (pre-)seed stage to series A, and support their evolution by providing funding, sharing our professional and academic connections, and helping to shape the business strategy in order to create value for all stakeholders.